Literature DB >> 26542209

Isolation of a Wickerhamomyces anomalus yeast strain from the sandfly Phlebotomus perniciosus, displaying the killer phenotype.

E Martin1, G Bongiorno2, L Giovati3, M Montagna4, E Crotti5, C Damiani6, L Gradoni2, L Polonelli3, I Ricci6, G Favia6, S Epis1.   

Abstract

The yeast Wickerhamomyces anomalus has been studied for its wide biotechnological potential, mainly for applications in the food industry. Different strains of W. anomalus have been isolated from diverse habitats and recently from insects, including mosquitoes of medical importance. This paper reports the isolation and phylogenetic characterization of W. anomalus from laboratory-reared adults and larvae of Phlebotomus perniciosus (Diptera: Psychodidae), a main phlebotomine vector of human and canine leishmaniasis. Of 65 yeast strains isolated from P. perniciosus, 15 strains were identified as W. anomalus; one of these was tested for the killer phenotype and demonstrated inhibitory activity against four yeast sensitive strains, as reported for mosquito-isolated strains. The association between P. perniciosus and W. anomalus deserves further investigation in order to explore the possibility that this yeast may exert inhibitory/killing activity against Leishmania spp.
© 2015 The Royal Entomological Society.

Entities:  

Keywords:  Leishmania; biocontrol; phlebotomine sandflies; yeast community

Mesh:

Substances:

Year:  2015        PMID: 26542209     DOI: 10.1111/mve.12149

Source DB:  PubMed          Journal:  Med Vet Entomol        ISSN: 0269-283X            Impact factor:   2.739


  8 in total

Review 1.  Microbial control of arthropod-borne disease.

Authors:  Miguel A Saldaña; Shivanand Hegde; Grant L Hughes
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02       Impact factor: 2.743

2.  A survey of the mycobiota associated with larvae of the black soldier fly (Hermetia illucens) reared for feed production.

Authors:  Ilaria Varotto Boccazzi; Matteo Ottoboni; Elena Martin; Francesco Comandatore; Lisa Vallone; Thomas Spranghers; Mia Eeckhout; Valeria Mereghetti; Luciano Pinotti; Sara Epis
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

3.  Candidacidal Activity of a Novel Killer Toxin from Wickerhamomyces anomalus against Fluconazole-Susceptible and -Resistant Strains.

Authors:  Laura Giovati; Claudia Santinoli; Elena Ferrari; Tecla Ciociola; Elena Martin; Claudio Bandi; Irene Ricci; Sara Epis; Stefania Conti
Journal:  Toxins (Basel)       Date:  2018-02-03       Impact factor: 4.546

4.  The Genomes of Four Meyerozyma caribbica Isolates and Novel Insights into the Meyerozyma guilliermondii Species Complex.

Authors:  Leone De Marco; Sara Epis; Aida Capone; Elena Martin; Jovana Bozic; Elena Crotti; Irene Ricci; Davide Sassera
Journal:  G3 (Bethesda)       Date:  2018-03-02       Impact factor: 3.154

5.  Killer yeasts exert anti-plasmodial activities against the malaria parasite Plasmodium berghei in the vector mosquito Anopheles stephensi and in mice.

Authors:  Alessia Cappelli; Matteo Valzano; Valentina Cecarini; Jovana Bozic; Paolo Rossi; Priscilla Mensah; Consuelo Amantini; Guido Favia; Irene Ricci
Journal:  Parasit Vectors       Date:  2019-07-02       Impact factor: 3.876

Review 6.  Wickerhamomyces anomalus in Mosquitoes: A Promising Yeast-Based Tool for the "Symbiotic Control" of Mosquito-Borne Diseases.

Authors:  Alessia Cappelli; Guido Favia; Irene Ricci
Journal:  Front Microbiol       Date:  2021-01-21       Impact factor: 5.640

7.  Formulation and Safety Tests of a Wickerhamomyces anomalus-Based Product: Potential Use of Killer Toxins of a Mosquito Symbiotic Yeast to Limit Malaria Transmission.

Authors:  Alessia Cappelli; Consuelo Amantini; Federica Maggi; Guido Favia; Irene Ricci
Journal:  Toxins (Basel)       Date:  2021-09-23       Impact factor: 4.546

Review 8.  Wickerhamomyces Yeast Killer Toxins' Medical Applications.

Authors:  Laura Giovati; Tecla Ciociola; Tiziano De Simone; Stefania Conti; Walter Magliani
Journal:  Toxins (Basel)       Date:  2021-09-15       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.